InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.

Dynamk Capital is a New York-based venture capital firm focused on life sciences, specifically investing in technologies and services that support the biopharmaceutical industry.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Dynamk Capital is an investment organization founded in 2016, dedicated to the life sciences sector. The firm collaborates with entrepreneurs and innovators to accelerate startups in life science industrials, providing essential technologies and services to the biopharmaceutical industry. With a focus on biotechnology, cell and gene therapies, vaccines, and regenerative medicine, Dynamk Capital aims to support the development of disruptive technologies that enhance the biopharma continuum. The firm operates from New York, New York, and has a portfolio that includes notable companies such as bit.bio and Alpenglow Biosciences.
Dynamk Capital invests in life sciences, specifically targeting start-ups that provide technologies and services to the biopharma sector. Their investment thesis includes a focus on biotechnology, cell and gene therapies, vaccines, and regenerative medicine.
Dynamk Capital provides hands-on commercialization and exit support through a team of entrepreneurs and industry executives, enhancing the growth and success of its portfolio companies.
Dynamk Capital focuses on life sciences startups that provide essential technologies and services to the biopharmaceutical industry. They look for companies innovating in biotechnology, cell and gene therapies, vaccines, and regenerative medicine.
Founders can pitch to Dynamk Capital through their website at dynamk.vc. It is advisable to include a detailed business plan and information about the technology or service being offered.
Dynamk Capital specializes in Life Science Industrials, focusing on the enabling technologies for biopharmaceuticals rather than just drug assets. This unique focus allows them to support a critical segment of the life sciences ecosystem.
The firm primarily invests in North America, specifically the United States, targeting startups that are positioned to make significant impacts in the life sciences sector.
Dynamk Capital invests across various stages, including Seed through Series A, B, and growth, although specific check sizes are not disclosed.
The firm provides hands-on commercialization and exit support through a team of entrepreneurs and industry executives, enhancing the growth and success of its portfolio companies.
Superscout Pro
Is this page right?Reviewed · How the research works